Clinical trial
Developing Brain Imaging Biomarkers to Quantify the Effects of At-home taVNS Treatment in ASD
NCT06698328 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Brain Imaging Biomarkers to Quantify the Effects of At-home taVNS Treatment in ASD
- Lead sponsor
- Medical University of South Carolina
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2025
- Completion date
- February 2, 2026
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autistic spectrum disorders